ERBB2 and breast cancer: In the United States, stage II and III HER2+ BC guidelines prescribe neoadjuvant/adjuvant chemotherapy regimen of doxorubicin/cyclophosphamide paclitaxel and docetaxel/carboplatin (12), however, systemic chemotherapy often brings many serious side effects.